Historical record - last NADAC effective date: 7/17/2024
Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0786 per EA under NDC 00781569092. Its NADAC has been published 365 times since Aug 9, 2017.
FDA first approved this application on Jun 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ezetimibe market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781569092
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA203931FDA Approved
6/12/2017
TE Code
AB
On Market Since
6/12/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 365 times since Aug 9, 2017, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0786 per EA |
|---|---|
| All-time high | $6.9413 (Aug 16, 2017) |
| All-time low | $0.0718 (May 22, 2024) |
| Median price | $0.1545 |
| Average price | $0.2482 |
| Largest weekly change | -88.2% (Sep 20, 2017) |
| Weeks tracked | 365 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-2.2%
5Y
-46.7%
All
-98.9%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Sandoz Inc., is $0.0786 per EA (NDC 00781569092), effective Jul 31, 2024.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 98.9%. It has been tracked across 365 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Aug 9, 2017, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0718 (May 22, 2024) to a high of $6.9413 (Aug 16, 2017), with a median of $0.1545 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0672 per EA — about 15% below EZETIMIBE 10 MG TABLET.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 00781569092) is labeled by Sandoz Inc., and CMS classifies it as a generic product.